ArticleMolecular genetics and metabolism reports2017

A pilot study on using rapamycin-carrying synthetic vaccine particles (SVP) in conjunction with enzyme replacement therapy to induce immune tolerance in Pompe disease.

Han-Hyuk Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.